Karen Kaucic
Chief Tech/Sci/R&D Officer bei PPD, INC.
Profil
Karen Kaucic ist Chief Medical Officer & Executive Vice President bei PPD, Inc. Dr. Kaucic erhielt einen Doktortitel von der Ohio State University.
Aktive Positionen von Karen Kaucic
Unternehmen | Position | Beginn |
---|---|---|
PPD, INC. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Karen Kaucic
Unternehmen | Position | Ende |
---|---|---|
Evidera, Inc.
Evidera, Inc. Miscellaneous Commercial ServicesCommercial Services Evidera, Inc. engages in provision of health economics, outcomes research, market access, data analytics and epidemiology services. It offers software for real-world data analytics, meta research, modeling and simulation, outcomes research, patient preferences, payer communications and strategy, precision and transformative technology solutions, and value and evidence planning. The company was founded in 2013 and is headquartered in Bethesda, MD. | President | - |
Ausbildung von Karen Kaucic
The Ohio State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Evidera, Inc.
Evidera, Inc. Miscellaneous Commercial ServicesCommercial Services Evidera, Inc. engages in provision of health economics, outcomes research, market access, data analytics and epidemiology services. It offers software for real-world data analytics, meta research, modeling and simulation, outcomes research, patient preferences, payer communications and strategy, precision and transformative technology solutions, and value and evidence planning. The company was founded in 2013 and is headquartered in Bethesda, MD. | Commercial Services |
PPD, Inc.
PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |